SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16169682
Source:
http://linkedlifedata.com/resource/pubmed/id/16169682
Search
Subject
(
57
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002844
,
umls-concept:C0205474
,
umls-concept:C0231174
,
umls-concept:C0376358
,
umls-concept:C0871712
,
umls-concept:C1522449
pubmed:issue
5
pubmed:dateCreated
2005-11-21
pubmed:abstractText
To compare several characteristics of alternative definitions of biochemical failure (BF) in men with extended follow-up after radiotherapy (RT) with or with androgen deprivation therapy (ADT) for prostate cancer.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Androgen Antagonists
,
http://linkedlifedata.com/resource/pubmed/chemical/Goserelin
,
http://linkedlifedata.com/resource/pubmed/chemical/Leuprolide
,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0360-3016
pubmed:author
pubmed-author:BuyyounouskiMark KMK
,
pubmed-author:EisenbergDebra FDF
,
pubmed-author:FeigenbergSteven JSJ
,
pubmed-author:HanlonAlexandra LAL
,
pubmed-author:HorwitzEric MEM
,
pubmed-author:PollackAlanA
,
pubmed-author:UzzoRobert GRG
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1455-62
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:16169682-Aged
,
pubmed-meshheading:16169682-Aged, 80 and over
,
pubmed-meshheading:16169682-Androgen Antagonists
,
pubmed-meshheading:16169682-Combined Modality Therapy
,
pubmed-meshheading:16169682-Follow-Up Studies
,
pubmed-meshheading:16169682-Goserelin
,
pubmed-meshheading:16169682-Humans
,
pubmed-meshheading:16169682-Leuprolide
,
pubmed-meshheading:16169682-Male
,
pubmed-meshheading:16169682-Middle Aged
,
pubmed-meshheading:16169682-Predictive Value of Tests
,
pubmed-meshheading:16169682-Proportional Hazards Models
,
pubmed-meshheading:16169682-Prostate-Specific Antigen
,
pubmed-meshheading:16169682-Prostatic Neoplasms
,
pubmed-meshheading:16169682-Radiotherapy, Conformal
,
pubmed-meshheading:16169682-Sensitivity and Specificity
,
pubmed-meshheading:16169682-Treatment Failure
pubmed:year
2005
pubmed:articleTitle
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer.
pubmed:affiliation
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. mark.buyyounouski@fccc.edu
pubmed:publicationType
Journal Article
,
Comparative Study
,
Evaluation Studies